Speakers

KEYNOTE SPEAKER

Alberto Bardelli

Dongxin Lin

Chinese Academy of Medical Sciences, Beijing, China

 

CONFIRMED SPEAKERS

Alberto Bardelli

Cory Abate-Shen

Columbia University Irving Comprehensive Cancer Center, New York, NY, USA

Mark S. Boguski

Adriana Albini

IRCCS MultiMedica, Milan, Italy

Andrew T. Chan

Nilofer S. Azad

Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA

Edward Chu

Anthony T.C. Chan

Chinese University of Hong Kong, Hong Kong

Chi Van Dang

Timothy A. Chan

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Michele De Palma

James CS Chim

Queen Mary Hospital, University of Hong Kong, Hong Kong

Jennifer Rubin Grandis

Melvin Lee Kiang Chua

Senior Consultant, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Assistant Professor, Duke-NUS Medical School

Meiyu Geng

Chen Dong 

Tsinghua University, Beijing, China

Jennifer Rubin Grandis

Zigang Dong

University of Minnesota Hormel Institute, Austin, MN, USA

James G. Herman

Wei-Qiang Gao

Shanghai Jiao Tong University, Shanghai, China

Jean-Pierre J. Issa

Tim F. Greten

National Cancer Institute, Bethesda, MD, USA

Thomas W. Kensler

Jin Gu

Peking University, Beijing, China

Gou Young Koh

Aida Habtezion

Stanford University School of Medicine, Palo Alto, CA, USA

Alberto Mantovani

Xiaojun Huang

Peking University, Beijing, China

Alberto Mantovani

Mien-Chie Hung

China Medical University, Taichung, Taiwan

Alberto Mantovani

Patrick Hwu

The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Amato J. Giaccia

Elizabeth M. Jaffee

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Amato J. Giaccia

Hongbin Ji

Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China

Amato J. Giaccia

Qunying Lei

Fudan University, Shanghai, China

Alberto Mantovani

Suet Yi Leung

The University of Hong Kong, Hong Kong

Dongxin Lin

Dongxin Lin

Chinese Academy of Medical Sciences, Beijing, China

Alberto Mantovani

Hui-Kuan Lin

Wake Forest University School of Medicine, Winston Salem, NC, USA

Alberto Mantovani

Shengcai Lin

Xiamen University School of Life Sciences, Xiamen, China

Alberto Mantovani

Ke Liu

U.S. Food and Drug Administration, Silver Spring, MD, USA

Alberto Mantovani

Brigette B. Ma

Chinese University of Hong Kong, Hong Kong

Carol R. Horowitz

Tak W. Mak

University of Toronto Health Network
Toronto, ON, Canada

Alberto Mantovani

Mao Mao

SeekIn, Inc., Shenzhen, China

Alberto Mantovani

Shannon L. Maude

Children’s Hospital of Philadelphia, Philadelphia, PA, USA

Alberto Mantovani

Chao-Nan Qian

Sun Yat-Sen University Cancer Center, Guangzhou, China

Alberto Mantovani

You-lin Qiao

Academy of Chinese Medicine, Beijing, China

Alberto Mantovani

Bruce Robinson

The University of Western Australia, Perth, Australia

Alberto Mantovani

Mark A. Rubin

University of Bern, Bern, Switzerland

Alberto Mantovani

Erwei Song

Sun Yat-Sen University, Guangzhou, China

Alberto Mantovani

Eduardo M. Sotomayor

George Washington University, Washington, DC, USA

Alberto Mantovani

Fuchou Tang

Peking University, Beijing, China

Alberto Mantovani

Nobu-hiro Tanuma

Miyagi Cancer Center Research Institute, Natori, Japan

Alberto Mantovani

Janis M. Taube

Johns Hopkins University School of Medicine, Baltimore, MD, USA

X. Shirley Liu

Hongyang Wang

National Center for Liver Cancer
Shanghai, China

X. Shirley Liu

Xiaodong Wang

National Institute of Biological Sciences, Beijing, China

Alberto Mantovani

Gonghong Wei

University of Oulu, Oulu, Finland

Sandra S. McAllister

Hong Wu

School of Life Science, Peking University, Beijing, China
 

Morag Park

Zengjun Xu

Center for Drug Evaluation, National Medical Products Administration, Beijing, China

Morag Park

Zhen Yang

Peking University
Shenzhen, China

Morag Park

Lars Zender

University Hospital Tübingen, Tübingen, Germany

Morag Park

Mu-Sheng Zeng

Sun Yat-Sen University Cancer Center, Guangzong, China

Morag Park

Zemin Zhang

Peking University, Beijing, China

Morag Park

Ping Zhu, Ph.D., B.M.

Vice President of Discovery & Research, H3 Biomedicine, Cambridge, MA, USA

 

*Additional speakers to be announced.